As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen COVID-19/flu combination test outside of emergency use authorization.
...Starting mid-October, airline passengers who have been in Rwanda in the last 21 days will have their travel to the United States rerouted” to one of three airports: Chicago O’Hare, JFK in New York and Washington Dulles in suburban Virginia, the Centers for Disease Control and Prevention said in a statement Monday.
The World Health Organization (WHO) has approved the first diagnostic test for mpox where the results can be immediately known, saying it could prove pivotal in helping to stop the rising global cases of the deadly virus.
The new PCR test enables the detection of the mpox DNA taken from skin lesion swabs.
Online nonprobability survey estimates suggest that 54 million US COVID-19 infections went uncounted in official records after home tests were widely deployed and institutional testing waned starting in February 2022. ...
